Metraipolis › archive › dc_86a5fc65e83b
Prolonged survival in EGFR exon 20 insertion mutant lung adenocarcinoma: case report of sequential osimertinib and furmonertinib with research trend analysis — Europe PMC PMID:41585239
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41585239
- DOI
- 10.3389/fmed.2025.1677737
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T23:07:07.527Z
- SHA-256 of the archived text
5dfd645879218e6559ee3a70becdd3612fc4cd4bf4087060e02a580edafb958a- Stable URL of this page
https://metraipolis.com/documento/dc_86a5fc65e83b
How to cite
Prolonged survival in EGFR exon 20 insertion mutant lung adenocarcinoma: case report of sequential osimertinib and furmonertinib with research trend analysis — Europe PMC PMID:41585239 — Europe PMC (en), https://europepmc.org/article/MED/41585239 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_86a5fc65e83b (Metraipolis archive dc_86a5fc65e83b, sha256 5dfd645879218e6559ee3a70becdd3612fc4cd4bf4087060e02a580edafb958a)
BibTeX
@misc{dc86a5fc65e83b,
title = {Prolonged survival in EGFR exon 20 insertion mutant lung adenocarcinoma: case report of sequential osimertinib and furmonertinib with research trend analysis — Europe PMC PMID:41585239},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41585239},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_86a5fc65e83b; sha256 5dfd645879218e6559ee3a70becdd3612fc4cd4bf4087060e02a580edafb958a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41585239. Agents can read the archived copy with the MCP tool read_document.